The most common cause of TKI resistance came from the occurrence of secondary EGFR mutation at the “gatekeeper” position 790 (T790M) in exon 20 (9), approximately contributing to 60% of the acquired resistance NSCLC cases (10, 11). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.